Gimv leads CHF55.5M ($61M) Series A financing in Anjarium Biosciences to develop novel non-viral gene therapies.
Anjarium Biosciences AG (“Anjarium”), a biotech company focused [...]
Anjarium Biosciences AG (“Anjarium”), a biotech company focused [...]
Pink Gellac, headquartered in Hilversum (The Netherlands), is [...]
Leuven, Belgium: 1 September 2021 — Qpinch, a [...]
23 August 2021 – Victus Participations, the investment [...]
Hilversum (NL), 6 August 2021 – Vendis Capital [...]
Begin deze maand heeft Investeringsmaatschappij Standard Investment de [...]
Funding expands growth for tiny chip-size sensors for [...]
RFS Holland Holding BV, moederbedrijf van online warenhuis [...]
Equipe Zorgbedrijven today announces an important step in [...]
The Belgian Venture Capital & Private Equity Association [...]